Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
2006

Testing for Lupus Anticoagulants in Heparin-Treated Patients

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Jacobsen Eva M, Trettenes Elin J, Wisløff Finn, Abildgaard Ulrich

Primary Institution: Haematological Research Laboratory, Ullevål University Hospital

Hypothesis

The study aimed to determine the influence and efficacy of heparin neutralisers in the Lupus Ratio assay.

Conclusion

The addition of polybrene allows for accurate determination of Lupus Ratios in both lupus anticoagulant-negative and positive plasmas, regardless of heparin presence.

Supporting Evidence

  • Polybrene was chosen as the most effective heparin neutraliser after testing several options.
  • The Lupus Ratio test can be reliably calculated in heparinised plasma after neutralisation with polybrene.
  • Only one negative test result became positive after the addition of polybrene, indicating its effectiveness.

Takeaway

Researchers found that adding a special substance called polybrene helps doctors test for a blood condition in patients who are receiving a blood thinner called heparin.

Methodology

The study tested several heparin neutralisers, focusing on polybrene, by comparing clotting times in normal plasma and plasma from patients with or without lupus anticoagulants.

Limitations

The study's results may not be applicable to all test systems due to differences in reagent composition.

Participant Demographics

The study included 30 healthy volunteers and 20 patients, with 12 having previously diagnosed lupus anticoagulants.

Digital Object Identifier (DOI)

10.1186/1477-9560-4-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication